Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Erickson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Beginnings (American Holistic Nurses' Association)|December 6, 2012
An interview with Helen Erickson, HNY 2012. Interview by Rebecca LaraHelen Erickson
Issues in Mental Health Nursing|October 7, 2017
THE COUNSELOR'S HANDBOOK: A PRACTICAL A?Z GUIDE TO PROFESSIONAL AND CLINICAL PRACTICEHelen Erickson
Progress in Retinal and Eye Research|December 18, 2019
Recapitulating developmental mechanisms for retinal regenerationIqbal Ahmad, Pooja Teotia, Helen Erickson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2025
Lipid nanomedicine simultaneously inhibits BRD4/PI3K and MDM2/XIAP signaling pathways for effective treatment of MedulloblastomaBharti Sethi, Aditya Gupta, Qiaoyu Pan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Beginnings (American Holistic Nurses' Association)|December 6, 2012
An interview with Helen Erickson, HNY 2012. Interview by Rebecca LaraHelen Erickson
Issues in Mental Health Nursing|October 7, 2017
THE COUNSELOR'S HANDBOOK: A PRACTICAL A?Z GUIDE TO PROFESSIONAL AND CLINICAL PRACTICEHelen Erickson
Progress in Retinal and Eye Research|December 18, 2019
Recapitulating developmental mechanisms for retinal regenerationIqbal Ahmad, Pooja Teotia, Helen Erickson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2025
Lipid nanomedicine simultaneously inhibits BRD4/PI3K and MDM2/XIAP signaling pathways for effective treatment of MedulloblastomaBharti Sethi, Aditya Gupta, Qiaoyu Pan, et al.
Pageof 1